Award
National Eye Institute 2R01EY031696-06
Innate and Adaptive Immunity in the Pathogenesis of Glaucoma
Recipient
Schepens Eye Research Institute
Award Amount
$834,935.00
Ceiling
$834,935.00
Awarded
June 23, 2026
Identifier
2R01EY031696-06
This NIH grant supports research on the immunological mechanisms underlying glaucoma, specifically the role of microglia and T cells in neuroinflammation and the potential therapeutic role of IGFBPL1.
Description
Research grant focused on understanding how microglia, T cells, and their interactions contribute to neuroinflammation and retinal ganglion cell loss in glaucoma, investigating the role of IGFBPL1 as an immunological checkpoint ligand to modulate neuroinflammation and potentially develop targeted therapies.